Policy / Pricing Makary resigns, with Diamantas named as acting FDA commissioner Pharmaceutical TechnologyThe resignation comes after reports suggested the President was considering firing him.Read full story pharminent May 12, 2026 (Last updated: May 16, 2026) Pharmaceutical Technology The resignation comes after reports suggested the President was considering firing him. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Arvinas, Pfizer find new partner for ‘Protac’ breast cancer drugNext: Isomorphic Labs receives $2.1bn for AI drug development Related Stories Policy / Pricing US launches probe of German ‘underpayment’ for medicines pharminent June 19, 2026 Policy / Pricing FDA’s new voucher program hints at broader policy agenda, making many ‘uncomfortable’ pharminent June 19, 2026 Policy / Pricing German said to be backtracking on pharma rebate changes pharminent June 16, 2026
